U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316270) titled 'SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)' on Dec. 15, 2025.
Brief Summary: SAFER-AF is an investigator-initiated, multicenter, open-label, parallel-group trial comparing catheter ablation versus usual care in patients with atrial fibrillation and intracerebral hemorrhage.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
AF - Atrial Fibrillation
ICH - Intracerebral Hemorrhage
Intervention:
PROCEDURE: Catheter Ablation
All patients undergo pulsed field ablation, followed by low-dose rivaroxaban for 1 month. For patients with paroxysmal atrial...